Sale!

SFTPA1 Gene Pulmonary Fibrosis Idiopathic NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SFTPA1 Gene Pulmonary Fibrosis Idiopathic NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the SFTPA1 gene associated with idiopathic pulmonary fibrosis. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide detailed insights into genetic predispositions for this serious lung condition. The test is particularly valuable for individuals with family history of pulmonary fibrosis, unexplained respiratory symptoms, or those seeking proactive health management. Results help guide personalized treatment approaches and inform family planning decisions. The test is available for $500 USD and provides results within 3-4 weeks using blood, extracted DNA, or blood spot samples.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SFTPA1 Gene Pulmonary Fibrosis Idiopathic NGS Genetic DNA Test

Comprehensive Genetic Analysis for Idiopathic Pulmonary Fibrosis

The SFTPA1 Gene Pulmonary Fibrosis Idiopathic NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for respiratory conditions. This advanced test specifically targets mutations in the SFTPA1 gene, which plays a crucial role in surfactant protein production essential for maintaining healthy lung function. Idiopathic pulmonary fibrosis is a progressive and often fatal lung disease characterized by scarring of lung tissue, and genetic testing provides critical insights for early detection and personalized management strategies.

What This Test Measures and Detects

Our comprehensive NGS-based genetic test analyzes the SFTPA1 gene to identify:

  • Pathogenic mutations associated with familial pulmonary fibrosis
  • Genetic variants that increase susceptibility to idiopathic pulmonary fibrosis
  • Specific SFTPA1 gene abnormalities affecting surfactant protein function
  • Inheritance patterns for family risk assessment
  • Genetic markers that influence disease progression and treatment response

Who Should Consider This Test

This genetic test is particularly recommended for individuals experiencing:

  • Unexplained shortness of breath or persistent dry cough
  • Family history of pulmonary fibrosis or interstitial lung disease
  • Progressive respiratory symptoms without clear diagnosis
  • Abnormal chest imaging findings suggestive of fibrosis
  • Multiple family members with respiratory conditions
  • Individuals planning family with known pulmonary fibrosis risk

Key Benefits of Genetic Testing

  • Early Detection: Identify genetic risk factors before symptoms become severe
  • Personalized Treatment: Guide targeted therapy approaches based on genetic profile
  • Family Planning: Inform reproductive decisions and family risk assessment
  • Proactive Monitoring: Enable regular screening for at-risk individuals
  • Peace of Mind: Provide clarity and reduce uncertainty about genetic risks
  • Comprehensive Analysis: NGS technology ensures thorough genetic evaluation

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and medical professionals:

  • Positive Result: Indicates presence of SFTPA1 gene mutation associated with pulmonary fibrosis risk
  • Negative Result: No detected mutations in the analyzed SFTPA1 gene regions
  • Variant of Uncertain Significance: Genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Information about genetic variants that may affect offspring

All results include detailed explanations and recommendations for next steps, including consultation with pulmonologists and genetic specialists.

Test Details and Pricing

Test Feature Details
Test Name SFTPA1 Gene Pulmonary Fibrosis Idiopathic NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Cardiologist, Genetics Department
Disease Category Cardiovascular Pneumology Disorders

Pre-Test Requirements

Before scheduling your test, we recommend:

  • Complete clinical history documentation of pulmonary fibrosis symptoms
  • Genetic counseling session to create detailed family pedigree chart
  • Discussion of test implications with healthcare provider
  • Understanding of potential outcomes and their significance

Nationwide Availability

We have convenient testing locations across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take Control of Your Respiratory Health

Don’t wait for symptoms to progress. Early genetic detection of SFTPA1 mutations can significantly impact your treatment journey and quality of life. Our comprehensive genetic testing provides the information you need to make informed healthcare decisions and work proactively with your medical team.

Ready to schedule your test? Call or WhatsApp us today at +1(267) 388-9828 to book your appointment or speak with our genetic counseling team. Take the first step toward understanding your genetic risk for idiopathic pulmonary fibrosis and developing a personalized health management plan.